.png)
designer491/iStock via Getty Images
Valneva (NASDAQ:VALN) said on Friday that the European Medicines Agency (EMA) has lifted the suspension on its chikungunya vaccine, Ixchiq, for adults aged 65 years and older.
The EMA's safety committee had previously paused the vaccine's use in May due
English (US) ·